London payments technology company Form3 has extended its Series C round to £46 million.
The fresh investment from British Patient Capital and existing shareholders, including Visa, values the company at around £436m.
A cloud-native account-to-account platform founded in 2016, Form3’s mission is to fundamentally change how technology in banking operates.
The funding will enable the firm to develop new products and services to help support exponential growth in key markets such as the UK, Europe and the US.
In 2021, Form3 raised £116m in a funding round led by Goldman Sachs.
“British Patient Capital’s investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world’s most established banks and financial institutions,” said CFO Benyam Hagos.
Listed FinTech CEO leaving podium ‘right decision for company’
Tom Haywood, managing director, direct investments at British Patient Capital, said: “Form3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure.
“We are delighted to support them as they take the next steps in their growth journey.”